首页 | 本学科首页   官方微博 | 高级检索  
     

(89)SrCL_2联合唑来膦酸治疗晚期肺癌骨转移瘤疼痛的临床应用价值
引用本文:张长弓,钱可宝,李高峰,叶联华,向旭东,陈楠. (89)SrCL_2联合唑来膦酸治疗晚期肺癌骨转移瘤疼痛的临床应用价值[J]. 中国医疗前沿, 2011, 0(19): 64-65
作者姓名:张长弓  钱可宝  李高峰  叶联华  向旭东  陈楠
作者单位:云南省肿瘤医院;昆明医学院附属第三医院肺癌研究中心;
摘    要:目的观察89SrCL2联合唑来膦酸在治疗晚期肺癌多发性骨转移瘤、缓解重度骨痛、改善生活质量等方面的疗效。方法对35例晚期肺癌骨转移瘤中重度疼痛的患者分别用89SrCL2联合唑来膦酸治疗。结果 89SrCL2联合唑来膦酸联合治疗组有效率为91.4%。结论用89SrCL2联合唑来膦酸治疗转移性骨肿瘤,能显著减轻患者中重度疼痛、提高生活质量,是一种有效且较安全、可靠的方法。

关 键 词:晚期肺癌  骨转移瘤  89SrCL2  唑来膦酸  疼痛

~(89)SrCL_2 joint zoledronic acid treatment of advanced lung cancer bone metastases pain value of clinical application
ZHANG Chang-gong,QIAN Ke-bao,LI Gao-feng,et al.. ~(89)SrCL_2 joint zoledronic acid treatment of advanced lung cancer bone metastases pain value of clinical application[J]. China Healthcare Innovation, 2011, 0(19): 64-65
Authors:ZHANG Chang-gong  QIAN Ke-bao  LI Gao-feng  et al.
Affiliation:ZHANG Chang-gong,QIAN Ke-bao,LI Gao-feng,et al.The Third of Kunming Medical College Hospital,Kunming 650118,China
Abstract:Objective To observe the 89SrCL2 joint zoledronic acid in the treatment of advanced lung cancer bone metastases,alleviate multiple severe bone pain,improve life quality,the effect of comparison.Methods Thirty-five patients with advanced cancer bone metastases moderate to severe pain patients respectively for 89SrCL2 joint zoledronic acid treatment.Results 89SrCL2 joint zoledronic acid combination therapy group,Effective rate was 91.4%.Conclusion 89SrCL2 joint zoledronic acid treatment metastatic bone tumors...
Keywords:Advanced cancer  Bone metastases  89SrCL2  Zoledronic acid  Pain  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号